Personalis Return on Tangible Equity 2018-2024 | PSNL

Current and historical return on tangible equity values for Personalis (PSNL) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Personalis Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-06-30 $-0.08B $0.11B -63.94%
2024-03-31 $-0.09B $0.12B -64.47%
2023-12-31 $-0.11B $0.13B -67.08%
2023-09-30 $-0.11B $0.15B -61.16%
2023-06-30 $-0.11B $0.18B -53.01%
2023-03-31 $-0.11B $0.19B -49.62%
2022-12-31 $-0.11B $0.22B -44.66%
2022-09-30 $-0.10B $0.24B -36.96%
2022-06-30 $-0.09B $0.27B -31.68%
2022-03-31 $-0.08B $0.29B -25.69%
2021-12-31 $-0.07B $0.31B -19.67%
2021-09-30 $-0.06B $0.33B -19.22%
2021-06-30 $-0.05B $0.34B -18.42%
2021-03-31 $-0.04B $0.35B -20.95%
2020-12-31 $-0.04B $0.20B -27.75%
2020-09-30 $-0.04B $0.20B -27.83%
2020-06-30 $-0.03B $0.09B -31.22%
2020-03-31 $-0.03B $0.10B -26.73%
2019-12-31 $-0.03B $0.11B -31.04%
2019-06-30 $-0.02B $0.12B -54.70%
2019-03-31 $-0.02B inf%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.270B $0.073B
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
BridgeBio Pharma (BBIO) United States $4.791B 0.00
Bausch Health Cos (BHC) Canada $3.597B 2.61
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Acasti Pharma (GRCE) Canada $0.031B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00